CAR- T as well as cell gene treatments are too pricey
.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and modern technology transactions can easily deliver cell gene treatments at an economical cost to people around the world.